Shopping Cart
- Remove All
- Your shopping cart is currently empty
PI3K/AKT-IN-1 is a dual PI3K and AKT inhibitor with anti-cancer activity. It inhibits PI3Kγ, PI3Kδ, and AKT, suppressing the PI3K/AKT pathway and inducing caspase 3-dependent apoptosis, suitable for cancer research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $71 | In Stock | |
5 mg | $172 | In Stock | |
10 mg | $242 | In Stock | |
25 mg | $416 | In Stock | |
50 mg | $565 | In Stock | |
100 mg | $826 | In Stock | |
1 mL x 10 mM (in DMSO) | $167 | In Stock |
Description | PI3K/AKT-IN-1 is a dual PI3K and AKT inhibitor with anti-cancer activity. It inhibits PI3Kγ, PI3Kδ, and AKT, suppressing the PI3K/AKT pathway and inducing caspase 3-dependent apoptosis, suitable for cancer research. |
Targets&IC50 | PI3Kγ:6.99 μM, PI3Kδ:4.01 μM, Akt:3.36 μM |
In vitro | PI3K/AKT-IN-1 showed excellent cytotoxic activity in breast cancer MCF-7 and leukemia K562 cell lines with IC50 values of 3.22 μM and 2.62 μM, respectively. PI3K/AKT-IN-1 causes the cell cycle to stall in the S phase, leading to apoptosis induced by caspase 3 activation of leukemia (k562) cells. [1] |
In vivo | The median lethal dose (LD50) of PI3K/AKT-IN-1 was greater than the test dose of 2000 mg/kg, indicating that PI3K/ AKt-in-1 was non-toxic and well tolerated by experimental animals. [1] |
Molecular Weight | 465.53 |
Formula | C23H23N5O4S |
Cas No. | 3033069-84-7 |
Smiles | N#CC=1C(=NC(=NC1C=2C=CC(OC)=CC2)SC)NN=CC3=CC(OC)=C(OC)C(OC)=C3 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 40 mg/mL (85.92 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.